MAST ERLE T
Insider CIK 1051411 · SOMX Director · ZGNX Director · RCPT Director · CLVS Executive VP and CFO · SNNA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 6,250 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 22,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 20,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | D To issuer deriv | 2022-03-07 | 2022-03-09 | 9,000 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | U Tender | 2022-03-07 | 2022-03-09 | 3,027 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2022-02-01 | 2022-02-03 | 1,250 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2022-02-01 | 2022-02-03 | 1,250 | $26.04 | $32.5K | 3,027 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2022-02-01 | 2022-02-03 | 1,250 | $12.00 | $15.0K | 4,277 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2022-01-19 | 2022-01-21 | 4,375 | — | $0 | 1,250 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2022-01-19 | 2022-01-21 | 4,375 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2022-01-19 | 2022-01-21 | 6,250 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2022-01-19 | 2022-01-21 | 4,375 | $12.00 | $52.5K | 18,027 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2022-01-19 | 2022-01-21 | 6,250 | $15.04 | $94.0K | 9,277 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2022-01-19 | 2022-01-21 | 4,375 | $14.88 | $65.1K | 13,652 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2022-01-19 | 2022-01-21 | 15,000 | $26.09 | $391.4K | 3,027 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2021-05-27 | 2021-05-28 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2020-05-29 | 2020-06-29 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2019-05-22 | 2019-05-28 | 13,000 | — | $0 | 13,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | S Sale | 2018-11-26 | 2018-11-26 | 1,468 | $42.08 | $61.8K | 3,027 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2018-10-02 | 2018-10-04 | 1,250 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise deriv | 2018-10-02 | 2018-10-04 | 218 | — | $0 | 0 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2018-10-02 | 2018-10-04 | 1,250 | $28.00 | $35.0K | 4,277 | SEC↗ |
| ZGNX ZOGENIX, INC. | M Exercise | 2018-10-02 | 2018-10-04 | 218 | $20.00 | $4.4K | 4,495 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | A Award deriv | 2018-06-01 | 2018-06-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2018-05-23 | 2018-05-24 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2017-08-01 | 2017-08-01 | 6,700 | $15.00 | $100.5K | 6,700 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2017-05-23 | 2017-05-23 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2016-07-13 | 2016-07-15 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-11-02 | 2015-11-03 | 400 | $105.10 | $42.0K | 137,383 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-11-02 | 2015-11-03 | 89 | $98.82 | $8.8K | 138,494 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-11-02 | 2015-11-03 | 111 | $100.80 | $11.2K | 138,383 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-11-02 | 2015-11-03 | 100 | $108.16 | $10.8K | 135,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-11-02 | 2015-11-03 | 700 | $107.29 | $75.1K | 135,683 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-11-02 | 2015-11-03 | 1,000 | $106.33 | $106.3K | 136,383 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-11-02 | 2015-11-03 | 500 | $104.28 | $52.1K | 137,783 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-11-02 | 2015-11-03 | 100 | $102.67 | $10.3K | 138,283 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-01 | 2015-10-02 | 900 | $89.40 | $80.5K | 140,683 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-01 | 2015-10-02 | 1,580 | $90.28 | $142.6K | 139,103 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-01 | 2015-10-02 | 420 | $91.30 | $38.3K | 138,683 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-10-01 | 2015-10-02 | 100 | $92.09 | $9.2K | 138,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-09-01 | 2015-09-03 | 1,000 | $79.39 | $79.4K | 142,983 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-09-01 | 2015-09-03 | 400 | $78.23 | $31.3K | 143,983 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-09-01 | 2015-09-03 | 100 | $81.07 | $8.1K | 141,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-09-01 | 2015-09-03 | 200 | $76.39 | $15.3K | 144,383 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-09-01 | 2015-09-03 | 1,300 | $80.34 | $104.4K | 141,683 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 18,800 | $213.23 | $4.01M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer deriv | 2015-08-27 | 2015-08-27 | 9,400 | $204.56 | $1.92M | 0 | SEC↗ |
| RCPT Receptos, Inc. | D To issuer | 2015-08-27 | 2015-08-27 | 7,400 | — | $0 | 0 | SEC↗ |
| RCPT Receptos, Inc. | U Tender | 2015-08-25 | 2015-08-27 | 300 | — | $0 | 7,400 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-08-03 | 2015-08-05 | 500 | $86.81 | $43.4K | 144,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-08-03 | 2015-08-05 | 1,310 | $86.33 | $113.1K | 145,083 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-08-03 | 2015-08-05 | 1,190 | $85.23 | $101.4K | 146,393 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-07-01 | 2015-07-02 | 900 | $86.56 | $77.9K | 147,683 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-07-01 | 2015-07-02 | 2,000 | $85.19 | $170.4K | 148,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-07-01 | 2015-07-02 | 100 | $88.01 | $8.8K | 147,583 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2015-06-18 | 2015-06-19 | 72,000 | — | $0 | 72,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-06-01 | 2015-06-03 | 400 | $90.87 | $36.3K | 150,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-06-01 | 2015-06-03 | 900 | $87.64 | $78.9K | 152,483 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-06-01 | 2015-06-03 | 1,000 | $88.90 | $88.9K | 151,483 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-06-01 | 2015-06-03 | 500 | $89.99 | $45.0K | 150,983 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-06-01 | 2015-06-03 | 200 | $86.04 | $17.2K | 153,383 | SEC↗ |
| RCPT Receptos, Inc. | A Award | 2015-05-28 | 2015-06-01 | 7,400 | — | $0 | 7,700 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-05-01 | 2015-05-05 | 1,800 | $81.98 | $147.6K | 153,904 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-05-01 | 2015-05-05 | 221 | $82.46 | $18.2K | 153,683 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-05-01 | 2015-05-05 | 100 | $83.55 | $8.4K | 153,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-05-01 | 2015-05-05 | 879 | $81.00 | $71.2K | 155,704 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-04-01 | 2015-04-03 | 100 | $72.65 | $7.3K | 156,683 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-04-01 | 2015-04-03 | 1,540 | $71.57 | $110.2K | 156,783 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-04-01 | 2015-04-03 | 1,260 | $70.52 | $88.9K | 158,323 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-04-01 | 2015-04-03 | 100 | $74.31 | $7.4K | 156,583 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award | 2015-03-13 | 2015-03-17 | 7,500 | $1.31 | $9.8K | 24,221 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-03-09 | 2015-03-11 | 8,400 | $78.78 | $661.8K | 160,183 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-03-09 | 2015-03-11 | 100 | $80.40 | $8.0K | 159,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2015-03-09 | 2015-03-11 | 500 | $79.56 | $39.8K | 159,683 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2015-03-02 | 2015-03-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2014-06-03 | 2014-06-05 | 9,400 | — | $0 | 9,400 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2014-05-21 | 2014-05-22 | 50,000 | — | $0 | 233,500 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2014-03-17 | 2014-03-18 | 100 | $51.55 | $5.2K | 300 | SEC↗ |
| RCPT Receptos, Inc. | P Buy | 2014-03-14 | 2014-03-18 | 200 | $50.23 | $10.0K | 200 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2014-01-10 | 2014-01-14 | 70,000 | — | $0 | 70,000 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-12-11 | 2013-12-12 | 24,023 | $51.64 | $1.24M | 168,683 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-12-11 | 2013-12-12 | 100 | $52.38 | $5.2K | 168,583 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-12-10 | 2013-12-12 | 700 | $54.57 | $38.2K | 192,706 | SEC↗ |
| CLVS Clovis Oncology, Inc. | S Sale | 2013-12-10 | 2013-12-12 | 25,177 | $53.81 | $1.35M | 193,406 | SEC↗ |
| RCPT Receptos, Inc. | A Award deriv | 2013-07-17 | 2013-07-19 | 18,800 | — | $0 | 18,800 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2013-06-18 | 2013-06-19 | 45,000 | — | $0 | 183,500 | SEC↗ |
| SOMX Pernix Sleep, Inc. | D To issuer | 2013-03-06 | 2013-03-08 | 39,162 | — | $0 | 0 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2013-03-01 | 2013-03-04 | 75,000 | — | $0 | 75,000 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-12-31 | 2013-01-03 | 7,820 | — | $0 | 34,781 | SEC↗ |
| ZGNX ZOGENIX, INC. | P Buy | 2012-12-11 | 2012-12-11 | 10,000 | $1.15 | $11.5K | 16,721 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-09-30 | 2012-10-02 | 57,414 | — | $0 | 215,694 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-07-02 | 2012-07-03 | 66,842 | — | $0 | 158,280 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2012-06-06 | 2012-06-06 | 35,000 | — | $0 | 138,500 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award deriv | 2012-05-31 | 2012-06-04 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ZGNX ZOGENIX, INC. | A Award deriv | 2012-04-27 | 2012-04-30 | 50,000 | — | $0 | 103,500 | SEC↗ |
| SOMX Somaxon Pharmaceuticals, I | A Award | 2012-04-02 | 2012-04-04 | 69,808 | — | $0 | 91,438 | SEC↗ |
| CLVS Clovis Oncology, Inc. | A Award deriv | 2012-03-01 | 2012-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |